Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Hedge Funds

13G Filing: 683 Capital Partners and Galmed Pharmaceuticals Ltd (GLMD)

Published on December 19, 2017 at 3:11 pm by Insider Monkey Staff in Hedge Funds
<< Prev
Page 6 of 9
Next >>
See All

Page 6 of 9 – SEC Filing

Item 3.
If This Statement is Filed Pursuant to Rule 13d 1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:
(a)
[ ]
Broker or dealer registered under Section 15 of the Exchange Act.
(b)
[ ]
Bank as defined in Section 3(a)(6) of the Exchange Act.
(c)
[ ]
Insurance company defined in Section 3(a)(19) of the Exchange Act.
(d)
[ ]
Investment company registered under Section 8 of the Investment Company Act.
(e)
[ ]
Investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).
(f)
[ ]
Employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F).
(g)
[ ]
Parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G).
(h)
[ ]
Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act.
(i)
[ ]
Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;
(j)
[ ]
Non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J).
(k)
[ ]
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).  If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____
Item 4. Ownership.
(a)
Amount beneficially owned:
As of December 6, 2017, 683 Capital Partners, LP beneficially owned 649,295 Ordinary Shares.
683 Capital Management, LLC, as the Investment Advisor of 683 Capital Partners, LP, may be deemed to have beneficially owned the 649,295 Ordinary Shares beneficially owned by 683 Capital Partners, LP.
Ari Zweiman, as the Managing Member of 683 Capital Management, LLC, may be deemed to have beneficially owned the 649,295 Ordinary Shares beneficially owned by 683 Capital Management, LLC.
(b)
Percent of Class:
The following percentage is based on 12,733,512 Ordinary Shares outstanding as of September 30, 2017 as disclosed in the Issuer’s report of foreign private issuer on Form 6-K filed with the Securities and Exchange Commission on November 9, 2017.
As of December 6, 2017, each of the Reporting Persons may be deemed to have beneficially owned approximately 5.1% of the outstanding Ordinary Shares.

Follow Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD)
<< Prev
Page 6 of 9
Next >>
See All

Related Insider Monkey Articles
13G Filing: Perceptive Advisors and Neptune Technologies & Bioressources Inc...13G Filing: Tourbillon Capital Partners and Green Plains Partners LP (GPP)
13G Filing: Perceptive Advisors and La Jolla Pharmaceutical Co (LJPC)13G Filing: Cove Street Capital and Westell Technologies Inc (WSTL)
13G Filing: Cannell Capital and Health Insurance Innovations Inc. (HIIQ)13G Filing: Perceptive Advisors and CytomX Therapeutics Inc (CTMX)